These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37104972)

  • 21. Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.
    Farkas MK; Kang H; Fogarasi A; Bozorg A; James GD; Krauwinkel W; Morita D; Will E; Elshoff JP
    Epilepsia; 2022 Apr; 63(4):855-864. PubMed ID: 35196395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals.
    Strzelczyk A; Steinig I; Willems LM; Reif PS; Senft C; Voss M; Gaida B; von Podewils F; Rosenow F
    Epilepsy Behav; 2017 May; 70(Pt A):177-181. PubMed ID: 28427029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study.
    Menzler K; Mross PM; Rosenow F; Schubert-Bast S; Willems LM; Zahnert F; Immisch I; Fuest S; von Podewils F; Kunz R; Hirsch M; Mueller T; Marquetand J; Winter Y; Langenbruch L; Cicanic M; Beyenburg S; Strzelczyk A; Knake S
    BMJ Open; 2019 Nov; 9(11):e030746. PubMed ID: 31690606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review.
    Lee K; Klein P; Dongre P; Choi EJ; Rhoney DH
    J Intensive Care Med; 2022 Sep; 37(9):1133-1145. PubMed ID: 35306914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
    Arnold S; Laloyaux C; Schulz AL; Elmoufti S; Yates S; Fakhoury T
    Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
    Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP
    Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis.
    Snoeren A; Majoie MHJM; Fasen KCFM; Ijff DM
    Seizure; 2022 Mar; 96():102-107. PubMed ID: 35184005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
    Stephen L; Brodie MJ
    Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review.
    Moalong KMC; Espiritu AI; Fernandez MLL
    J Neurol Sci; 2020 Jun; 413():116799. PubMed ID: 32278203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
    Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
    Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid intravenous loading of brivaracetam during invasive and non-invasive video-EEG monitoring.
    Chavarría B; Zucca R; Principe A; Sanabria A; Rocamora R
    Epilepsy Res; 2023 May; 192():107145. PubMed ID: 37087911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.
    Brandt C; Klein P; Badalamenti V; Gasalla T; Whitesides J
    Epilepsy Behav; 2020 Feb; 103(Pt A):106864. PubMed ID: 31937513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, tolerability and pharmacokinetic variability of brivaracetam in adults with difficult-to-treat epilepsy.
    Svendsen T; Brodtkorb E; Linge HL; Burns ML; Johannessen SI; Nakken KO; Lossius MI; Landmark CJ
    Epilepsy Res; 2022 Jul; 183():106946. PubMed ID: 35609355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis.
    Moseley BD; Dimova S; Elmoufti S; Laloyaux C; Asadi-Pooya AA
    Epilepsy Res; 2021 Oct; 176():106694. PubMed ID: 34218211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
    Villanueva V; Laloyaux C; D'Souza W; Faught E; Klein P; Reuber M; Rosenow F; Salas-Puig J; Insuga VS; Strzelczyk A; Szaflarski JP; Chinn C; Daniels T; Floricel F; Friesen D; Sendersky V; Besson H; Steinhoff BJ
    CNS Drugs; 2023 Sep; 37(9):819-835. PubMed ID: 37684497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.